Universe Pharmaceuticals UPC Balance Sheet (2020-2026)

NASDAQ UPC
$3.54 -0.36 (-9.05%)
As of: Oct 20, 2026 · 3:38 PM EDT
Reported Financials

Universe Pharmaceuticals Quarterly Balance Sheet

Periods 12 quarters
Latest Mar 2026

Universe Pharmaceuticals reported total assets of $0.07B and total liabilities of $0.02B for the quarter ended Mar 2026, up 44.6% year over year. This balance sheet covers 12 quarters of results from Sep 2020 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 10.06M0.20M8.08M14.24M5,711.46M12.95M5,285.25M8.86M29.50M47.27M33.59M27.56M
Short-term InvestmentsInvestments (Current) 13.73M0.70M13.15M13.31M1.37M2.53M1,377.87M1.49M
Cash & Current Investments 10.06M0.20M21.80M14.93M5,724.61M26.27M5,286.61M11.39M1,407.37M47.27M33.59M29.05M
Receivables - NetNet Receivables 10.87M17.80M15.57M18.82M15.18M17.52M11.01M14.38M12,905.82M10,170,413.00M13.01M14.96M
Receivables - OtherOther Receivables 0.24M0.36M1.92M5,666.60M3,355,316.00M2.28M7.18M
Receivables 10.87M17.80M15.81M19.17M15.18M17.52M12.94M14.38M18,572.42M13,525,729.00M15.29M22.14M
Raw Materials 2.74M1.39M0.99M0.43M0.64M0.55M978.20M2.49M2.00M
Work In Process 0.26M0.54M
Finished Goods 1.97M1.84M1.34M1.94M2.78M2.87M1,141.53M1.61M1.20M
Inventory 1,906,232.00M4.92M2.74M3.39M2.21M2.87M3.34M3.39M1,737.05M3,565,953.00M2.49M2.00M
Prepaid Assets 3.09M0.17M0.42M1.72M2.01M0.07M0.54M852.42M39,179.00M0.04M0.04M
Current Assets 23,279,921.00M61.81M50.48M51.66M41.51M52.52M25.27M33.53M51,637.78M65,025,544.00M53.60M55.21M
Non-Current Assets
Construction in Progress 0.45M
Property, Plant & Equipment (Net)PP&E (Net) 4,428,064.00M4.40M4.68M4.99M4.25M4.14M3.70M3.52M3,568.05M3,289,105.00M3.58M3.79M
Long-Term Investments 20.80M0.76M0.74M0.59M0.70M0.73M702.35M0.69M712.49M689,018.00M0.70M0.72M
Intangibles 0.17M0.18M0.15M0.16M0.16M0.16M0.15M0.15M262.88M266,783.00M0.30M0.31M
Goodwill & Intangibles 0.17M0.18M0.15M0.16M0.16M0.16M0.15M0.15M262.88M266,783.00M0.30M0.31M
Long-Term Deferred Tax 186,537.00M0.12M0.87M0.99M1.35M0.83M0.60M
Other Non-Current Assets 443,709.00M2.44M2.44M0.04M0.10M36.32M
Non-Current Assets 5,524,377.00M5.47M19.66M19.71M18.03M17.85M16.45M15.90M16,315.61M15,641,615.00M15.70M16.26M
Assets 28,804,298.00M67.27M70.14M71.37M59.54M70.37M41.72M49.43M67,953.39M80,667,159.00M69.30M71.47M
Liabilities
Current Liabilities
Accounts Payables 2,691,193.00M8.59M5.31M3.65M3.08M11.24M4.59M7.76M4,914.76M7,400,655.00M1.67M3.75M
Notes Payables 2,646,000.00M2.75M4.33M4.41M3.94M5.44M5.48M4.43M5,856.70M5,663,731.00M7.15M7.38M
Payables 5,337,193.00M11.33M9.64M8.06M7.01M16.68M10.07M12.20M10,771.47M13,064,386.00M8.82M11.13M
Accumulated Expenses 375,960.00M0.69M0.44M1.18M2.54M2.16M2.71M2.73M49.48M1,646,095.00M262,621.00M251,872.00M
Other Accumulated Expenses 956,492.00M3.12M0.44M0.35M2.54M5.44M1.08M11.03M13,801.17M8,585,187.00M0.89M0.31M
Short term Debt 2.11M
Current Taxes 0.12M0.07M1.52M0.96M0.69M0.33M0.43M0.17M1,021.18M119,483.00M0.64M0.66M
Current Deferred Revenue 0.04M0.04M
Total Current Liabilities 8,001,394.00M16.58M11.21M10.21M13.10M23.24M13.75M20.61M20,312.97M23,415,151.00M13.17M13.65M
Non-Current Liabilities
Non-Current Debt 2.08M2,137.48M2,067,055.00M2.17M
Other Non-Current Liabilities 2,439,535.00M2.44M2.44M2,439,535.00M2.44M2,439,535.00M0.19M2,439,535.00M2,439,535.00M2,439,535.00M2,439,535.00M
Total Non-Current Liabilities 26,364,742.20M14.14M20.71M-2,474,805.99M20.80M-2,467,463.43M22.49M2,137.48M78,227,568.82M-2,439,521.83M-2,439,519.18M
Total Liabilities 28,804,277.20M16.58M23.15M10.21M-35,270.99M23.24M-27,928.43M22.69M67,907.89M80,667,103.82M13.17M15.82M
Shareholder's Equity
Total Debt 2,646,000.00M2.75M4.33M4.41M3.94M5.44M5.48M6.51M7,994.19M7,730,786.00M9.26M9.55M
Common Equity 20.80M50.69M46.99M61.16M35,330.53M47.13M27,970.15M26.74M45.50M55.18M56.13M55.65M
Liabilities and Shareholders Equity 28,804,298.00M67.27M70.14M71.37M59.54M70.37M41.72M49.43M67,953.39M80,667,159.00M69.30M71.47M
Retained Earnings 13,738,979.00M20.89M25.06M26.79M16.32M15.61M-1.44M-2.94M-10,171.57M-13,456,323.00M-13.84M-15.40M

Universe Pharmaceuticals Balance Sheet API

Pull Universe Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=UPC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY